Fate Therapeutics, Inc.FATENASDAQ
LOADING
|||
Trailing Twelve Months (TTM) Metrics
Per Share (TTM)
Revenue/Share$0.06
Net Income/Share$-1.31
Operating CF/Share$-0.93
Free CF/Share$-0.97
Cash/Share$1.81
Book Value/Share$1.97
Tangible Book/Share$1.97
Equity/Share$1.97
Interest Debt/Share$0.67
CapEx/Share$0.04
Dividend/Share$0.00
Valuation
Market Cap$142.46M
Enterprise Value$181.08M
P/E Ratio-0.94P/S Ratio19.96P/OCF Ratio-1.33
P/FCF Ratio-1.23
P/B Ratio0.63P/TB Ratio0.63
EV/Sales25.37EV/EBITDA-1.29
Graham Valuation
Graham Number--
Graham Net-Net$0.89
Profitability
Earnings Yield-106.21%FCF Yield-81.03%ROE-56.63%ROIC-54.55%Return on Tangible Assets-45.42%Dividend
Dividend Yield0.00%Payout Ratio0.00%Capital Allocation
CapEx/OCF-4.39%
CapEx/Revenue68.08%
CapEx/Depreciation0.33
SBC/Revenue399.55%
SG&A/Revenue716.24%
R&D/Revenue1625.51%
Liquidity & Solvency
Debt/Equity0.34Debt/Assets0.23Debt/Market Cap0.56
Net Debt/EBITDA-0.28
Current Ratio7.87Interest Coverage0.00xIncome Quality0.71Efficiency
Days Sales Outstanding35 days
Days Payables Outstanding0 days
Days Inventory0 days
Receivables Turnover10.46x
Payables Turnover0.00x
Inventory Turnover0.00x
Capital Structure
Tangible Assets$234.07M
Working Capital$193.14M
Invested Capital$295.03M
Intangibles/Assets0.00%